Influence of adjuvant radiotherapy on circulating epithelial tumor cells and circulating cancer stem cells in primary non-metastatic breast cancer-Reference-Cited by-同舟云学术

Influence of adjuvant radiotherapy on circulating epithelial tumor cells and circulating cancer stem cells in primary non-metastatic breast cancer

Published:2021-03 Issue:3 Volume:14 Page:101009
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Schott Dorothea Sonja,Pizon Monika,Pachmann Ulrich,Pachmann Katharina,Schobert Rainer^ORCID,Wittig Andrea,Mäurer Matthias

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference46 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA: A Cancer J. Clinic.,2018

2. Clinical outcomes with neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer: a report from the National Cancer Database. Coleman WB, editor;Bagegni;PLOS ONE,2019

3. Circulating tumor cells, disease recurrence and survival in newly diagnosed breast cancer;Franken;Breast Cancer Res.,2012

4. Radiation therapy and early breast cancer: current controversies;Boyages;Med. J. Aust.,2017

5. Integration of a radiosensitivity molecular signature into the assessment of local recurrence risk in breast cancer;Torres-Roca;Int. J. Radiat. Oncol. Biol. Phys.,2015

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CTCs in Early Breast Cancer;Circulating Tumor Cells;2023

2. Increased Circulating Epithelial Tumor Cells (CETC/CTC) over the Course of Adjuvant Radiotherapy Is a Predictor of Less Favorable Outcome in Patients with Early-Stage Breast Cancer;Current Oncology;2022-12-24

3. New inflammatory indicators for cell-based liquid biopsy: association of the circulating CD44+/CD24− non-hematopoietic rare cell phenotype with breast cancer residual disease;Journal of Cancer Research and Clinical Oncology;2022-09-13

4. An exploratory study on the checkout rate of circulating tumor cells and the prediction of efficacy of neoadjuvant therapy and prognosis in patients with HER-2-positive early breast cancer;Frontiers in Oncology;2022-08-04

5. Chick Chorioallantoic Membrane (CAM) Assays as a Model of Patient-Derived Xenografts from Circulating Cancer Stem Cells (cCSCs) in Breast Cancer Patients;Cancers;2022-03-14